Avid Bioservices Newsroom

Avid Bioservices Analyst Ratings

BenzingaJul 3 09:45 ET

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

TipRanksJul 3 06:48 ET

Avid Bioservices (CDMO) Receives a Buy From Craig-Hallum

TipRanksJul 1 09:32 ET

Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)

TipRanksMay 8 09:06 ET

Avid Bioservices Analyst Ratings

BenzingaApr 30 13:11 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)

TipRanksApr 30 08:45 ET

Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)

TipRanksApr 30 06:45 ET

Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)

TipRanksApr 25 09:11 ET

Analysts' Top Healthcare Picks: Avid Bioservices (CDMO), LifeMD (LFMD)

TipRanksApr 16 08:45 ET

Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)

TipRanksApr 1 08:40 ET

Avid Bioservices Analyst Ratings

BenzingaMar 11 11:01 ET

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

TipRanksMar 7 20:51 ET

Avid Bioservices Analyst Ratings

BenzingaMar 7 08:52 ET

Analysts Are Bullish on Top Healthcare Stocks: Alimera (ALIM), Avid Bioservices (CDMO)

TipRanksMar 7 08:45 ET

Analysts' Top Healthcare Picks: Trulieve Cannabis (TCNNF), Avid Bioservices (CDMO)

TipRanksFeb 29 09:30 ET

Analysts Are Bullish on Top Healthcare Stocks: Science 37 (SNCE), Avid Bioservices (CDMO)

TipRanksJan 29 08:50 ET

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

BenzingaDec 8, 2023 12:11 ET

Avid Bioservices Analyst Ratings

BenzingaDec 8, 2023 12:10 ET

RBC Cuts Price Target on Avid Bioservices to $7 From $15, Cites Slower Revenue Growth Assumptions Amid 'Challenging' Demand Backdrop; Outperform Kept

MT NewswiresDec 8, 2023 07:09 ET

Keybanc Maintains Overweight on Avid Bioservices, Lowers Price Target to $14

BenzingaDec 8, 2023 04:22 ET